Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinogenicity studies on ebrotidine

A Romero1, A Rives, M T Grau

  • 1Centro de Investigación Farmacéutica Grupo Ferrer, Barcelona, Spain.

Arzneimittel-Forschung
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility preservation in boys: recent developments and new insights <sup>†</sup>.

Human reproduction open·2020
Same author

Sperm chromatin condensation defects, but neither DNA fragmentation nor aneuploidy, are an independent predictor of clinical pregnancy after intracytoplasmic sperm injection.

Journal of assisted reproduction and genetics·2019
Same author

Evaluation of apoptotic- and autophagic-related protein expressions before and after IVM of fresh, slow-frozen and vitrified pre-pubertal mouse testicular tissue.

Molecular human reproduction·2017
Same author

Assessment of sperm nuclear quality after in vitro maturation of fresh or frozen/thawed mouse pre-pubertal testes.

Molecular human reproduction·2017
Same author

Influence of collagen concentration and glutaraldehyde on collagen-based scaffold properties.

Journal of biomedical materials research. Part A·2016
Same author

Motion reduction and multidimensional denoising in Voltage-sensitive Dye imaging.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2016
Same journal

Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

Arzneimittel-Forschung·2013
Same journal

Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

Arzneimittel-Forschung·2013
Same journal

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012
Same journal

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012
Same journal

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012
Same journal

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012
See all related articles

Ebroditine did not cause cancer in mice or rats. Some general toxicity effects were observed at high doses, including decreased survival in female mice and reduced weight gain in rats.

Area of Science:

  • Toxicology
  • Carcinogenicity studies

Background:

  • Ebroditine (CAS 100981-43-9) is a compound investigated for potential health effects.
  • Carcinogenicity studies are crucial for assessing the long-term safety of pharmaceutical compounds.

Purpose of the Study:

  • To evaluate the carcinogenic potential of ebrotidine in rodent models.
  • To determine if ebrotidine induces neoplastic or preneoplastic changes.

Main Methods:

  • Two carcinogenicity studies were conducted in mice (18 months) and rats (24 months).
  • Animals received oral doses of ebrotidine up to 500 mg/kg, following EEC guidelines.
  • Statistical analysis used International Agency for Research on Cancer recommendations; weekly monitoring and histopathology were performed.

Main Results:

Related Experiment Videos

  • Ebroditine administration showed minimal toxicity: decreased survival in female mice (500 mg/kg) and reduced weight gain in rats.
  • Increased incidence of lipoid pneumonia and kidney calculi observed in rats at higher doses (300-500 mg/kg).
  • No significant increase in tumor occurrence or preneoplastic changes was detected in treated animals compared to controls.

Conclusions:

  • Ebroditine does not appear to induce neoplastic or preneoplastic effects in rats or mice.
  • General toxicity effects were observed at high doses, but these did not correlate with tumor development.